×
About 517 results

ALLMedicine™ Tractional Retinal Detachment Center

Research & Reviews  257 results

Recent trends in drug-delivery systems for the treatment of Diabetic Retinopathy and as...
https://doi.org/10.1016/j.addr.2021.04.007
Advanced Drug Delivery Reviews; Silva M, Peng T et. al.

Apr 15th, 2021 - Diabetic retinopathy is a frequent microvascular complication of diabetes and a major cause of visual impairment. In advanced stages, the abnormal neovascularization can lead to fibrosis and subsequent tractional retinal detachment and blindness. ...

Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review o...
https://doi.org/10.1097/ICU.0000000000000760 10.1186/s12886-020-01688-3
Current Opinion in Ophthalmology; Berrocal MH, Acaba-Berrocal L

Mar 26th, 2021 - Diabetic retinopathy (DR) is one of the leading causes of preventable vision loss in the world and its prevalence continues to increase worldwide. One of the ultimate and visually impairing complications of DR is proliferative diabetic retinopathy...

Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993849
PloS One; Chen PL, Chen YT et. al.

Mar 25th, 2021 - To compare surgical outcomes between 27 and 25-gauge vitrectomy in proliferative diabetic retinopathy (PDR) with tractional retinal detachment (TRD). This retrospective study was conducted to compare the intraoperative status, operation time, use ...

Anti-VEGF Crunch Syndrome in Proliferative Diabetic Retinopathy: A Review.
https://doi.org/10.1016/j.survophthal.2021.03.001
Survey of Ophthalmology; Tan Y, Fukutomi A et. al.

Mar 11th, 2021 - Anti-vascular endothelial growth factor (anti-VEGF) crunch syndrome describes the progression to tractional retinal detachment following intravitreal anti-VEGF therapy in an eye with proliferative diabetic retinopathy (PDR). We reviewed the litera...

The effect of intravitreal recombinant tissue plasminogen activator injection on diabet...
https://doi.org/10.1177/1120672121998224
European Journal of Ophthalmology; Ghasemi Falavarjani K, Anvari P et. al.

Mar 3rd, 2021 - To evaluate the effect of intravitreal recombinant tissue plasminogen activator (tPA) on diabetic tractional fibrovascular membranes (FVM) using proposed optical coherence tomography (OCT) criteria. This prospective, interventional case series enr...

see more →

Clinicaltrials.gov  259 results

Recent trends in drug-delivery systems for the treatment of Diabetic Retinopathy and as...
https://doi.org/10.1016/j.addr.2021.04.007
Advanced Drug Delivery Reviews; Silva M, Peng T et. al.

Apr 15th, 2021 - Diabetic retinopathy is a frequent microvascular complication of diabetes and a major cause of visual impairment. In advanced stages, the abnormal neovascularization can lead to fibrosis and subsequent tractional retinal detachment and blindness. ...

Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review o...
https://doi.org/10.1097/ICU.0000000000000760 10.1186/s12886-020-01688-3
Current Opinion in Ophthalmology; Berrocal MH, Acaba-Berrocal L

Mar 26th, 2021 - Diabetic retinopathy (DR) is one of the leading causes of preventable vision loss in the world and its prevalence continues to increase worldwide. One of the ultimate and visually impairing complications of DR is proliferative diabetic retinopathy...

Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993849
PloS One; Chen PL, Chen YT et. al.

Mar 25th, 2021 - To compare surgical outcomes between 27 and 25-gauge vitrectomy in proliferative diabetic retinopathy (PDR) with tractional retinal detachment (TRD). This retrospective study was conducted to compare the intraoperative status, operation time, use ...

Anti-VEGF Crunch Syndrome in Proliferative Diabetic Retinopathy: A Review.
https://doi.org/10.1016/j.survophthal.2021.03.001
Survey of Ophthalmology; Tan Y, Fukutomi A et. al.

Mar 11th, 2021 - Anti-vascular endothelial growth factor (anti-VEGF) crunch syndrome describes the progression to tractional retinal detachment following intravitreal anti-VEGF therapy in an eye with proliferative diabetic retinopathy (PDR). We reviewed the litera...

The effect of intravitreal recombinant tissue plasminogen activator injection on diabet...
https://doi.org/10.1177/1120672121998224
European Journal of Ophthalmology; Ghasemi Falavarjani K, Anvari P et. al.

Mar 3rd, 2021 - To evaluate the effect of intravitreal recombinant tissue plasminogen activator (tPA) on diabetic tractional fibrovascular membranes (FVM) using proposed optical coherence tomography (OCT) criteria. This prospective, interventional case series enr...

see more →

News  1 results

Promising Therapies for Diabetic Eye Disease on the Way: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/68284

Oct 3rd, 2017 - One expert describes promising strategies for treating diabetic eye disease. A recent study provides new insights into how to prevent tractional retinal detachment from developing or progressing in patients with severe proliferative diabetic retin...

see more →